TY  - JOUR
PY  - 2023//
TI  - Screening for depression and suicide risk in adults: US Preventive Services Task Force recommendation statement
JO  - JAMA journal of the American Medical Association
A1  - Barry, Michael J.
A1  - Nicholson, Wanda K.
A1  - Silverstein, Michael
A1  - Chelmow, David
A1  - Coker, Tumaini Rucker
A1  - Davidson, Karina W.
A1  - Davis, Esa M.
A1  - Donahue, Katrina E.
A1  - Jaén, Carlos Roberto
A1  - Li, Li
A1  - Ogedegbe, Gbenga
A1  - Pbert, Lori
A1  - Rao, Goutham
A1  - Ruiz, John M.
A1  - Stevermer, James J.
A1  - Tsevat, Joel
A1  - Underwood, Sandra Millon
A1  - Wong, John B.
SP  - 2057
EP  - 2067
VL  - 329
IS  - 23
N2  - IMPORTANCE: Major depressive disorder (MDD), a common mental disorder in the US, may have substantial impact on the lives of affected individuals. If left untreated, MDD can interfere with daily functioning and can also be associated with an increased risk of cardiovascular events, exacerbation of comorbid conditions, or increased mortality. <br><br>OBJECTIVE: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate benefits and harms of screening, accuracy of screening, and benefits and harms of treatment of MDD and suicide risk in asymptomatic adults that would be applicable to primary care settings. POPULATION: Asymptomatic adults 19 years or older, including pregnant and postpartum persons. Older adults are defined as those 65 years or older. EVIDENCE ASSESSMENT: The USPSTF concludes with moderate certainty that screening for MDD in adults, including pregnant and postpartum persons and older adults, has a moderate net benefit. The USPSTF concludes that the evidence is insufficient on the benefit and harms of screening for suicide risk in adults, including pregnant and postpartum persons and older adults. RECOMMENDATION: The USPSTF recommends screening for depression in the adult population, including pregnant and postpartum persons and older adults. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons and older adults. (I statement).<p />  <p>Language: en</p>
LA  - en
SN  - 0098-7484
UR  - http://dx.doi.org/10.1001/jama.2023.9297
ID  - ref1
ER  -